Log in

OTCMKTS:TECRTechCare Stock Price, Forecast & News

$0.24
+0.01 (+4.35 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.21
Now: $0.24
$0.24
50-Day Range
$0.12
MA: $0.17
$0.24
52-Week Range
$0.01
Now: $0.24
$0.58
Volume14,820 shs
Average Volume58,966 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TechCare Corp., a technology company, engages in the design, development, and commercialization of a platform utilizing proprietary vaporization technology to enable health, wellness, and beauty treatments in the Netherlands and in Israel. Its products include Novokid, a device for the treatment of head lice and eggs; and Shine, a device for the treatment and rejuvenation of the hair and scalp. The company is headquartered in Rosh HaAyin, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.38 out of 5 stars


Industry, Sector and Symbol

Industry Household & Personal Products
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:TECR
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees10
Next Earnings Date6/15/2020 (Estimated)
OptionableNot Optionable

Receive TECR News and Ratings via Email

Sign-up to receive the latest news and ratings for TECR and its competitors with MarketBeat's FREE daily newsletter.

TechCare (OTCMKTS:TECR) Frequently Asked Questions

How has TechCare's stock been impacted by COVID-19 (Coronavirus)?

TechCare's stock was trading at $0.2601 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TECR stock has decreased by 7.7% and is now trading at $0.24. View which stocks have been most impacted by Coronavirus.

When is TechCare's next earnings date?

TechCare is scheduled to release its next quarterly earnings announcement on Monday, June 15th 2020. View our earnings forecast for TechCare.

Has TechCare been receiving favorable news coverage?

News articles about TECR stock have been trending somewhat negative on Sunday, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. TechCare earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutTechCare.

Who are some of TechCare's key competitors?

What other stocks do shareholders of TechCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TechCare investors own include Stereotaxis (STXS), United Microelectronics (UMC), Taseko Mines (TGB), Pyxus International (PYX), Escalon Medical (ESMC) and Evans & Sutherland Computer (ESCC).

Who are TechCare's key executives?

TechCare's management team includes the following people:
  • Mr. Zvi Yemini, Chairman & CEO (Age 68)
  • Ms. Tali Dinar, Chief Financial Officer (Age 47)
  • Tabe Ydo, Chief Marketing Officer
  • Michel Vd Bergh, Chief Commercial Officer
  • Mr. Laurence Alexander, European Chief Exec. Officer

What is TechCare's stock symbol?

TechCare trades on the OTCMKTS under the ticker symbol "TECR."

How do I buy shares of TechCare?

Shares of TECR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is TechCare's stock price today?

One share of TECR stock can currently be purchased for approximately $0.24.

What is TechCare's official website?

The official website for TechCare is www.techcareltd.com.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.